South Wales, Jan. 8 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "KLEOS" on Nov. 18, 2025. The details about the trademark application no. UK00004296455 published in the journal no. 2025/052 (Dec. 26, 2025).
With Scintilla Intellectual Property Ltd as representative, OPALMEDICA LIMITED filed the trademark application for the below mentioned good(s)/service(s).
Class 9 : Software; computer application software; computer software relating to the medical field; computer software for use in medical decision support systems; health monitoring software; AI software; artificial intelligence software for healthcare; computer software for applications, databases, and data integration; computer software for database management; computer software for application and database integration and analysis; software for use in database management; computer software for database management and for collecting, processing, viewing, managing, sharing, integrating, analysing, and storing data; computer software for providing data access, reporting, performing research and analysis for use in the delivery and management of healthcare; computer software for use in the diagnosis of medical conditions and diseases; platform software; computer software for developing and integrating artificial intelligence, namely, machine learning, deep learning, and natural language processing, which are capable of collecting, organising and analysing data; computer software featuring medical, clinical and other healthcare information for use in medical education and by providers of medical services; databases; interactive databases; computer software for accessing databases; computer software for application and database integration; computer software to enable searching and retrieval of data; software for use in the identification of medical symptoms; software for use by healthcare providers; computer software for database management, for running applications, for integrating applications and for health information systems; data communications software; interactive computer software enabling exchange of information; artificial intelligence software for use in identifying symptoms and aiding in the diagnosis of medical conditions and diseases; computer software based on artificial intelligence for formulating conclusions based on available data; software based on artificial intelligence used for the support decision making process for use in the field of medicine.
Class 42 : Software as a service [SaaS]; Software as a service [SaaS] featuring software for use in the field of medicine; Software as a Service [SaaS] featuring software used for the support decision making process for use in the field of medicine; Software as a Service [SaaS] featuring software for deep learning; design, rental, leasing, hiring, maintenance, updating and development of computer software; providing temporary use of web-based applications; providing temporary use of on-line, non-downloadable software for database management and for collecting , processing, viewing, managing, sharing, integrating, analysing, and storing data; providing temporary use of on-line, non-downloadable software for providing data access, reporting, performing research and analysis for use in the delivery and management of healthcare; Software as a Service [SaaS] services featuring software for artificial intelligence; design, installation, updating and rental of computer software in the field of medical solutions; design, installation, updating and rental of application programming interface (API) for use with information technology equipment in the field of medicine; design, installation, updating and implementation of computer software for formulating conclusions based on available data; design, installation, updating and implementation of computer software used for the support decision making process for use in the field of medicine; Platform as a Service [PaaS]; Artificial intelligence as a service (AIAAS); information, advisory and consultancy services relating to all the aforesaid.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004296455
Disclaimer: Curated by HT Syndication.
